ArticleFrontiers in pharmacology2025

Shikonin as a therapeutic agent in renal cell carcinoma: insights from TEK-related causal association with glaucoma.

Ruyue Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.